The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

P. S.C. Rees; S. M. Davidson; S. E. Harding; C. McGregor; P. M. Elliot; D. M. Yellon; D. J. Hausenloy

doi:10.1007/s10557-013-6447-z

The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

P. S.C. Rees, S. M. Davidson, S. E. Harding, C. McGregor, P. M. Elliot, D. M. Yellon, D. J. Hausenloy

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	235-237
Number of pages	3
Journal	Cardiovascular Drugs and Therapy
Volume	27
Issue number	3
DOIs	https://doi.org/10.1007/s10557-013-6447-z
State	Published - Jun 2013
Externally published	Yes

Bibliographical note

Funding Information:
Acknowledgments The authors are grateful for the support of the British Heart Foundation (grant number FS/06/023). This study was carried out at the Heart Hospital/University College London Hospital and University College London, which received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme.

Keywords

Atorvastatin
Ciclosporin-A
Hypertrophic cardiomyopathy
MPTP
Myocardial ischemia-reperfusion injury

Access

10.1007/s10557-013-6447-z

OpenUrl availability

Full text

Cite this

@article{4e239cb30ebb481c98562a0a43e1abd2,

title = "The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy",

keywords = "Atorvastatin, Ciclosporin-A, Hypertrophic cardiomyopathy, MPTP, Myocardial ischemia-reperfusion injury",

author = "Rees, {P. S.C.} and Davidson, {S. M.} and Harding, {S. E.} and C. McGregor and Elliot, {P. M.} and Yellon, {D. M.} and Hausenloy, {D. J.}",

note = "Funding Information: Acknowledgments The authors are grateful for the support of the British Heart Foundation (grant number FS/06/023). This study was carried out at the Heart Hospital/University College London Hospital and University College London, which received a proportion of funding from the Department of Health{\textquoteright}s NIHR Biomedical Research Centres funding scheme.",

year = "2013",

month = jun,

doi = "10.1007/s10557-013-6447-z",

language = "English (US)",

volume = "27",

pages = "235--237",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "3",

}

TY - JOUR

T1 - The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

AU - Rees, P. S.C.

AU - Davidson, S. M.

AU - Harding, S. E.

AU - McGregor, C.

AU - Elliot, P. M.

AU - Yellon, D. M.

AU - Hausenloy, D. J.

N1 - Funding Information: Acknowledgments The authors are grateful for the support of the British Heart Foundation (grant number FS/06/023). This study was carried out at the Heart Hospital/University College London Hospital and University College London, which received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme.

PY - 2013/6

Y1 - 2013/6

KW - Atorvastatin

KW - Ciclosporin-A

KW - Hypertrophic cardiomyopathy

KW - MPTP

KW - Myocardial ischemia-reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=84887357985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887357985&partnerID=8YFLogxK

U2 - 10.1007/s10557-013-6447-z

DO - 10.1007/s10557-013-6447-z

M3 - Article

C2 - 23380984

AN - SCOPUS:84887357985

SN - 0920-3206

VL - 27

SP - 235

EP - 237

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 3

ER -

The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Cite this